Upadacitinib Outperforms Mycophenolate in SSc-ILD Treatment ...Middle East

Medscape - News
Upadacitinib Outperforms Mycophenolate in SSc-ILD Treatment
Patients treated with upadacitinib have lower rates of lung function decline with no significant adverse events. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Upadacitinib Outperforms Mycophenolate in SSc-ILD Treatment )

Apple Storegoogle play

Also on site :